Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross‐sectional imaging in a tertiary care setting
Open Access
- 29 July 2024
- journal article
- research article
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (7) , 870-878
Abstract
Background: Stricturing, penetrating complications and extraintestinal manifestations (EIMs) are frequent in patients with inflammatory bowel disease (IBD). There is limited data on the prevalence of these complications in patients with IBD. Therefore, we aimed to assess the burden of these complications detected incidentally on cross‐sectional imaging. Methods: A retrospective study conducted at two tertiary care centers in London, Ontario. Patients (≥18 years) with a confirmed diagnosis of IBD who underwent CT enterography (CTE) or MR enterography (MRE) between 1 Jan 2010 and 31 Dec 2018 were included. Categorical variables were reported as proportions and the mean and standard deviations were reported for continuous variables. Results: A total of 615 imaging tests (MRE: 67.3% [414/615]) were performed in 557 IBD patients (CD: 91.4% [509/557], UC: 8.6% [48/557]). 38.2% (213/557) of patients were male, with mean age of 45.6 years (±15.8), and median disease duration of 11.0 years (±12.5). Among patients with CD, 33.2% (169/509) had strictures, with 7.8% having two or more strictures and 66.3% considered inflammatory. A fistula was reported in 10.6% (54/509), the most common being perianal fistula (27.8% [15/54]), followed by enterocutaneous fistula (16.8% [9/54]), and enteroenteric fistula (16.8% [9/54]). Additionally, 7.4% (41/557) of patients with IBD were found to have an EIM on cross‐sectional imaging, with the most prevalent EIM being cholelithiasis (63.4% [26/41]), followed by sacroiliitis (24.4% [10/41]), primary sclerosing cholangitis (4.8% [2/41]) and nephrolithiasis (4.8% [2/41]). Conclusions: Approximately 40% of patients with CD undergoing cross‐sectional imaging had evidence of a stricture or fistulizing disease, with 7% of patients with IBD having a detectable EIM. These results highlight the burden of disease and the need for specific therapies for these disease phenotypes.Keywords
This publication has 35 references indexed in Scilit:
- Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisInflammatory Bowel Diseases, 2023
- Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's diseaseUnited European Gastroenterology Journal, 2022
- Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature reviewInternational Immunopharmacology, 2022
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology, 2021
- Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in DenmarkClinical Gastroenterology and Hepatology, 2019
- Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesisExpert Review of Gastroenterology & Hepatology, 2019
- Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL CohortAmerican Journal of Gastroenterology, 2017
- Extraintestinal manifestations and complications in IBDNature Reviews Gastroenterology & Hepatology, 2013
- Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease CohortAmerican Journal of Gastroenterology, 2011
- Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up StudyClinical Gastroenterology and Hepatology, 2007